A comment on 'Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials'

被引：0
|
作者：
Goldenberg, Ronald M. [1 ,2 ]
机构：
[1] LMC Diabet & Endocrinol, Vaughan, ON, Canada
[2] LMC Diabet & Endocrinol, 1600 Steeles Ave West 5, Vaughan, ON L4K 4M2, Canada
来源：
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 07期
关键词：
D O I：
10.1111/dom.15588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2997 / 2999
页数：3
相关论文
共 50 条
  • [21] Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials With Meta-Analysis
    Bellastella, Giuseppe
    Maiorino, Maria Ida
    Longo, Miriam
    Scappaticcio, Lorenzo
    Chiodini, Paolo
    Esposito, Katherine
    Giugliano, Dario
    STROKE, 2020, 51 (02) : 666 - 669
  • [22] Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review
    De Ycaza, Ana E. Espinosa
    Brito, Juan P.
    McCoy, Rozalina G.
    Shao, Hui
    Ospina, Naykky Singh
    THYROID, 2024, 34 (04) : 403 - 418
  • [23] Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials
    Ilaria Dicembrini
    Besmir Nreu
    Alessia Scatena
    Francesco Andreozzi
    Giorgio Sesti
    Edoardo Mannucci
    Matteo Monami
    Acta Diabetologica, 2017, 54 : 933 - 941
  • [24] Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: systematic review and meta-analysis
    Singh, Sahib
    Rahman, Syed Hamaad
    Khan, Nihal
    Rajagopal, Anjali
    Shafique, Nouman
    Tawde, Poonam
    Bhardwaj, Vaishali
    Kumar, Vishnu Charan Suresh
    Aswath, Ganesh
    Inamdar, Sumant
    Dutta, Sudhir
    Hurairah, Abu
    Mohan, Babu P.
    GASTROINTESTINAL ENDOSCOPY, 2025, 101 (02)
  • [25] The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes A Meta-Analysis of Randomized Placebo-Controlled Trials
    Mendonca, Luis
    Moura, Henrique
    Chaves, Paulo Castro
    Neves, Joao Sergio
    Ferreira, Joao Pedro
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 20 (02): : 159 - 168
  • [26] Effect of glucagon-like peptide-1 receptor agonists on circulating levels of leptin and resistin: A meta-analysis of randomized controlled trials
    Simental-Mendia, Luis E.
    Sanchez-Garcia, Adriana
    Linden-Torres, Enrique
    Simental-Mendia, Mario
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [27] Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials
    Monami, Matteo
    Zannoni, Stefania
    Pala, Laura
    Silverii, Antonio
    Andreozzi, Francesco
    Sesti, Giorgio
    Mannucci, Edoardo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 : 414 - 421
  • [28] EFFECT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS ON BODY COMPOSITION - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Pasam, Ravi Teja
    Bi, Danse
    Jirapinyo, Pichamol
    Thompson, Christopher C.
    GASTROENTEROLOGY, 2024, 166 (05) : S598 - S599
  • [29] Efficacy of glucagon-like peptide-1 receptor agonists for psoriasis: An updated systematic review and meta-analysis
    Ku, Su-Chi
    Chang, Hua-Ching
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 (08): : 1148 - 1152
  • [30] Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis
    Berg, Sara
    Stickle, Hannah
    Rose, Suzanne J.
    Nemec, Eric C.
    OBESITY REVIEWS, 2025,
12345